IDNA vs. SBIO ETF Comparison

Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to ALPS Medical Breakthroughs ETF (SBIO)
IDNA

iShares Genomics Immunology and Healthcare ETF

IDNA Description

The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Grade (RS Rating)

Last Trade

$21.84

Average Daily Volume

36,386

Number of Holdings *

40

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$31.81

Average Daily Volume

12,975

Number of Holdings *

84

* may have additional holdings in another (foreign) market
Performance
Period IDNA SBIO
30 Days -8.62% -9.22%
60 Days -6.43% -12.18%
90 Days -2.33% 0.02%
12 Months -8.67% 5.77%
13 Overlapping Holdings
Symbol Grade Weight in IDNA Weight in SBIO Overlap
ACLX D 2.67% 1.96% 1.96%
ARCT F 1.0% 0.54% 0.54%
BCRX F 1.28% 0.64% 0.64%
DCPH D 0.94% 0.81% 0.81%
FDMT D 1.25% 0.9% 0.9%
GERN A 2.17% 1.31% 1.31%
MGNX B 1.36% 0.7% 0.7%
NTLA F 0.49% 1.41% 0.49%
RCUS F 1.05% 0.97% 0.97%
RVMD A 5.56% 4.01% 4.01%
SWTX D 2.69% 2.15% 2.15%
VIR F 1.02% 0.76% 0.76%
XNCR F 0.27% 0.78% 0.27%
IDNA Overweight 27 Positions Relative to SBIO
Symbol Grade Weight
SRPT D 5.37%
MRNA A 4.88%
MRK B 4.44%
REGN C 4.11%
EXEL A 3.76%
INCY F 3.7%
IOVA D 3.29%
GILD F 3.22%
BNTX F 3.19%
BGNE F 2.85%
BEAM F 2.35%
TWST D 2.28%
DVAX D 1.94%
DNA F 1.74%
LGND B 1.69%
BPMC A 1.24%
ABCL F 1.1%
CRSP F 1.08%
IBRX B 1.0%
NRIX A 0.96%
EDIT F 0.67%
OABI F 0.62%
NVAX F 0.6%
VALN C 0.56%
CRBU F 0.4%
CVAC F 0.34%
QURE F 0.27%
IDNA Underweight 71 Positions Relative to SBIO
Symbol Grade Weight
CERE B -5.04%
VKTX B -4.79%
PCVX D -4.53%
ALPN A -2.84%
ALKS F -2.67%
CRNX A -2.28%
AXSM F -2.19%
XENE D -2.1%
IDYA D -2.04%
ACAD F -1.89%
IMCR D -1.79%
SMMT D -1.67%
CLDX D -1.67%
CORT F -1.63%
DNLI F -1.62%
MRUS D -1.57%
VERA D -1.57%
RYTM D -1.56%
VCEL B -1.54%
ARVN D -1.53%
KROS D -1.4%
GLPG F -1.31%
RNA A -1.28%
CPRX A -1.23%
SNDX D -1.22%
INBX C -1.1%
AGIO B -1.09%
EWTX D -1.04%
PTGX D -1.02%
ZLAB F -0.96%
KURA D -0.95%
MORF F -0.94%
TARS B -0.88%
VRNA F -0.88%
DAWN B -0.86%
IRWD F -0.83%
AKRO F -0.82%
PRTA F -0.77%
MIRM F -0.75%
MNKD D -0.74%
LQDA D -0.69%
VRDN F -0.64%
MDXG F -0.62%
ZNTL F -0.61%
ETNB F -0.59%
SPRY B -0.59%
OPK C -0.57%
PLRX F -0.54%
IRON F -0.49%
AUPH F -0.49%
KNSA D -0.47%
SVRA C -0.47%
AVTE B -0.44%
ALLO F -0.4%
OLMA F -0.4%
CMPS F -0.38%
ANAB D -0.38%
ALEC F -0.34%
MLYS F -0.33%
FULC D -0.31%
TVTX F -0.31%
REPL F -0.3%
BMEA F -0.29%
ITOS D -0.27%
AURA F -0.24%
AVXL F -0.23%
ENTA C -0.22%
INZY F -0.2%
RAPT F -0.19%
VNDA A -0.16%
RPHM C -0.04%
Compare ETFs